CBLL
Ceribell, Inc.$27.03 −0.10 (−0.37%)
Oct 26 4:00 PM ET · prev $27.13
Market cap
$1.1B
Small cap
Consensus
Buy
93% Buy or better · 14 analysts
Median target
$29.00
+7% · range $24.00–33.00
Next earnings
Nov 3
in 8 days · EPS est. −$0.52
1 year
+109.7%
from $12.89 · Oct 27
30 days
+10.3%
from $24.51
52-week range
$10.92–27.68
−2% from high · low Nov 4
Avg volume 20D
446.9K
shares / day
Short interest
2.02M
≈5.3% of shares · +10.9%
Days to cover
5.0
at average volume
Insider net
−$10.3M
0 buyers · 8 sellers · since Jun 8
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read MIXED 12 reports · 90 days
Balance 3 bearish · 2 bullish · 1 mixed · 6 neutral oldest → newest, height = score
Avg score ·High conf. 7/12 ·Next Earnings date, Nov 3, 2026
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- S Jun 8 to Jun 11 2 days of insider sells: $357.9K by 2 insiders, avg $18.35
- S Jun 26 to Jul 7 3 days of insider sells: $4.9M by 3 insiders, avg $20.08
- S Aug 3 1 insider sell $714.5K at $18.32
- R Aug 10 Ceribell reported Q2 2026 revenue of $28.1M (+33% YoY), beating the…
- R Aug 10 Ceribell reported Q2 2026 revenue of $28.1M (+33% YoY, beating conse…
- S Aug 13 to Aug 24 5 days of insider sells: $2.3M by 6 insiders, avg $24.66
- S Sep 2 to Sep 15 3 days of insider sells: $1.9M by 4 insiders, avg $24.67
- S Oct 1 1 insider sell $119.1K at $24.38
Signal stack
Where each data set points today.
- InsidersBEARISH
8 insiders sold $10.3M.
- InstitutionsBULLISH
Q2 2026: 12 added (0 new), 8 trimmed or exited.
- AnalystsBULLISH
13 of 14 rate it Buy or better. Median target $29.00 (+7%).
- EstimatesFALLING
Current-quarter EPS estimate −$0.370 → −$0.515 over 90 days. 0 up, 4 down in 30 days.
- Short sellersSTEADY
Short interest +10.9% to 2.02M shares. 5.0 days to cover, ≈5.3% of shares.
- TrendUPTREND
9% above its 50-day average. New closing high $27.68 on Oct 20.
Who's buying
13F· Q2 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC | ADD | $14.1M |
| GOLDMAN SACHS GROUP INC | TRIM | $5.5M |
| BANK OF AMERICA CORP /DE/ | TRIM | $4.6M |
| CITADEL ADVISORS LLC | TRIM | $3.8M |
| JANE STREET GROUP, LLC | DOUBLED | $3.4M |
| D. E. Shaw & Co., Inc. | ADD | $2.9M |
| CITIGROUP INC | ADD | $1.6M |
| BARCLAYS PLC | ADD | $861.7K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
14 analysts 93% rate it Buy or better
12-month targets · 7 analysts
$27.03 $24.00 $29.00 $33.00
Price is inside the target range. Median implies +7%.Targets as of Oct 26, 2026.
Recent actions
| Date | Firm | Rating |
|---|---|---|
| Oct 2, 2026 | TD Cowen MAINTAIN | Buy |
| Sep 11, 2026 | BTIG REITERATE | Buy |
| Aug 18, 2026 | BTIG MAINTAIN | Buy |
| Aug 11, 2026 | Canaccord Genuity MAINTAIN | Buy |
| Aug 11, 2026 | BTIG REITERATE | Buy |
| May 12, 2026 | Canaccord Genuity MAINTAIN | Buy |
Insider ledger
Form 4$0
bought · 0 insiders
$10.3M
sold · 8 insiders
| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 1, 2026 | Woo Raymond Chief Technology Officer | SELL | $119.1K |
| Oct 1, 2026 | Woo Raymond Chief Technology Officer | EXERCISE | $17.8K |
| Oct 1, 2026 | Woo Raymond Chief Technology Officer | EXERCISE | $108.10 |
| Sep 15, 2026 | Blumberg Scott Chief Financial Officer | EXERCISE | $8.0K |
| Sep 15, 2026 | Blumberg Scott Chief Financial Officer | SELL | $21.1K |
| Sep 15, 2026 | Chao Xingjuan President and CEO | SELL | $521.8K |
| Sep 8, 2026 | Woo Raymond Chief Technology Officer | EXERCISE | $18.8K |
| Sep 8, 2026 | Woo Raymond Chief Technology Officer | EXERCISE | $17.8K |
Earnings setup
EstimatesNov 3
reports in 8 days
−$0.52
EPS estimate, this quarter
−39%
estimate change, 90 days
0↑ 4↓
revisions, 30 days
Current-quarter EPS estimate
−$0.37090d
−$0.37060d
−$0.51530d
−$0.5157d
−$0.515Now
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.52 | -$0.55–-$0.48 | +0.0% | $29.2M |
| Next Q | -$0.43 | -$0.48–-$0.40 | +0.0% | $31.7M |
| Current FY | -$1.96 | -$2.06–-$1.87 | +0.0% | $115.5M |
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Sep 30, 20262,017,836
shares short
+10.9%
vs prior settlement
5.0
days to cover
≈5.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 20, 2026 SEC Sep 10, 2026 SEC
Ceribell announced it will report its Q3 2026 results on November 3, 2026.
PRESS-RELEASE — Impact 1/10
Oct 20, 2026 Earnings
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
SUNNYVALE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a m
Oct 1, 2026 Insider
Woo Raymond sold 4,887 shares
Chief Technology Officer @ $24.38 ($119.1K)
Oct 1, 2026 Insider
Woo Raymond acquired via exercise 4,864 shares
Chief Technology Officer @ $3.65 ($17.8K)
Oct 1, 2026 Insider
Sep 17, 2026 SEC Woo Raymond acquired via exercise 23 shares
Chief Technology Officer @ $4.70 ($108.10)
Three Ceribell insiders, including the CFO and CTO, sold a total of $183K in open-market sales over a one-week window…
CLUSTER — Impact 3/10
Ceribell CEO and CFO sold a combined $989K in stock on September 2, 2026, with the CEO alone selling $973K (39.5K…
CLUSTER — Impact 5/10
Jun 30, 2026 Inst.
MILLENNIUM MANAGEMENT LLC — ADD
727,225 shares ($14.1M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Oct 20, 2026
Earnings
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
SUNNYVALE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on…
Aug 10, 2026
Earnings
Ceribell Reports Second Quarter 2026 Financial Results
SUNNYVALE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on…
Aug 10, 2026
Earnings date
CBLL Q2 2026 Earnings Scheduled — 2026-08-10
Aug 3, 2026
Press release
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
Incremental NTAP Reimbursement Stands to Broaden Access to First-of-Its-Kind Dual Seizure and Delirium Monitoring Platform Incremental NTAP…
Jul 29, 2026
Press release
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
Medtech Market-Builder Thomas West and Health System Operator Sharon O’Keefe Join Ceribell as Point-of-Care Brain Monitoring Advances Toward…
SecBot reports
29 filings · 3 bullish · 8 bearish · 2 mixed · 16 neutral- NEUTRAL PRESS-RELEASEOct 20, 2026
Ceribell announced it will report its Q3 2026 results on November 3, 2026.
- NEUTRAL CLUSTERSep 17, 2026
Three Ceribell insiders, including the CFO and CTO, sold a total of $183K in open-market sales…
Monitor for any follow-on insider sales or a pattern of larger dispositions. The current cluster is too small to warrant a bearish read.
- BEARISH CLUSTERSep 10, 2026
Ceribell CEO and CFO sold a combined $989K in stock on September 2, 2026, with the CEO alone…
Ceribell CEO and CFO sold a combined $989K in stock on September 2, 2026, with the CEO alone selling $973K (39.5K shares at $24.61). CTO Raymond Woo also exercised and sold $119K on September 8. The…
- NEUTRAL CLUSTERSep 4, 2026
CEO Xingjuan Chao and CFO Scott Blumberg sold a combined $989K in open-market shares on September…
The insider sales are modest relative to market cap and appear to be routine option exercise and diversification. No immediate bearish read-through. Monitor for any subsequent filings or news that…
All CBLL filing & press-release reports (29)
- PRESS-RELEASE reportOct 20, 2026
- CLUSTER reportSep 17, 2026
- CLUSTER reportSep 10, 2026
- CLUSTER reportSep 4, 2026
- CLUSTER reportAug 25, 2026
- CLUSTER reportAug 20, 2026
- CLUSTER reportAug 20, 2026
- INST-CLUSTER reportAug 18, 2026
- 8-K reportAug 10, 2026
- PRESS-RELEASE reportAug 10, 2026
- 3 reportJul 30, 2026
- 3 reportJul 30, 2026
- CLUSTER reportJul 9, 2026
- 144 reportJun 30, 2026
- CLUSTER reportJul 2, 2026
- CLUSTER reportJun 15, 2026
- CLUSTER reportMay 26, 2026
- PRESS-RELEASE reportMay 11, 2026
- CLUSTER reportMay 1, 2026
- PRESS-RELEASE reportApr 20, 2026
- DEFA14A reportApr 20, 2026
- CLUSTER reportApr 1, 2026
- CLUSTER reportFeb 24, 2026
- CLUSTER reportFeb 23, 2026
- INST-CLUSTER reportFeb 28, 2026
- CLUSTER reportFeb 23, 2026
- CLUSTER reportFeb 23, 2026
- CLUSTER reportFeb 23, 2026
- 8-K, 8-K reportFeb 24, 2026